887644-46-4Relevant academic research and scientific papers
Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-D-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase
Kantsadi, Anastassia L.,Bokor, éva,Kun, Sándor,Stravodimos, George A.,Chatzileontiadou, Demetra S.M.,Leonidas, Demetres D.,Juhász-Tóth, éva,Szakács, Andrea,Batta, Gyula,Docsa, Tibor,Gergely, Pál,Somsák, László
supporting information, p. 737 - 745 (2016/08/17)
C-β-D-Glucopyranosyl pyrrole derivatives were prepared in the reactions of pyrrole, 2-, and 3-aryl-pyrroles with O-peracetylated β-D-glucopyranosyl trichloroacetimidate, while 2-(β-D-glucopyranosyl) indole was obtained by a cross coupling of O-perbenzylated β-D-glucopyranosyl acetylene with N-tosyl-2-iodoaniline followed by spontaneous ring closure. An improved synthesis of O-perbenzoylated 2-(β-D-glucopyranosyl) imidazoles was achieved by reacting C-glucopyranosyl formimidates with α-aminoketones. The deprotected compounds were assayed with isoforms of glycogen phosphorylase (GP) to show no activity of the pyrroles against rabbit muscle GPb. The imidazoles proved to be the best known glucose derived inhibitors of not only the muscle enzymes (both a and b) but also of the pharmacologically relevant human liver GPa (Ki?=?156 and 26?nM for the 4(5)-phenyl and -(2-naphthyl) derivatives, respectively). An X-ray crystallographic study of the rmGPb-imidazole complexes revealed structural features of the strong binding, and also allowed to explain the absence of inhibition for the pyrrole derivatives.
Synthesis of β-analogues of C-mannosyltryptophan, a novel C-glycosylamino acid found in proteins
Nishikawa, Toshio,Koide, Yuya,Kanakubo, Akira,Yoshimura, Hiroshi,Isobe, Minoru
, p. 1268 - 1277 (2007/10/03)
α-C-Mannosyltryptophan (α-C-Man-Trp) has been found to be a novel post-translational modification of tryptophan found from some biologically important glycoproteins. In order to analyze the biological functions of α-C-Man-Trp, we have developed an efficie
